The aim of this study is to determine whether giving extra arginine, a simple amino acid, to
patients with sickle cell disease seeking treatment for a pain crisis (vaso-occlusive painful
events (VOE) will decrease pain scores, decrease the need for pain medications or decrease
length of hospital stay or emergency department visit. Funding Source - FDA OOPD.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborators:
Children's Healthcare of Atlanta National Center for Complementary and Integrative Health (NCCIH)